Logo image of PCN

PIMCO CORPORATE & INCOME STR (PCN) Stock Price, Quote, News and Overview

NYSE:PCN - New York Stock Exchange, Inc. - US72200U1007 - Currency: USD

12.62  +0.1 (+0.8%)

After market: 12.6984 +0.08 (+0.62%)

Fundamental Rating

2

PCN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. PCN may be in some trouble as it scores bad on both profitability and health. PCN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

PCN had positive earnings in the past year.
Of the past 5 years PCN 4 years were profitable.
Of the past 5 years PCN 4 years had a positive operating cash flow.
PCN Yearly Net Income VS EBIT VS OCF VS FCFPCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

The last Return On Invested Capital (5.85%) for PCN is above the 3 year average (5.35%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.35%
ROE 6.52%
ROIC 5.85%
ROA(3y)4.24%
ROA(5y)4.86%
ROE(3y)6.8%
ROE(5y)6.95%
ROIC(3y)5.35%
ROIC(5y)5.2%
PCN Yearly ROA, ROE, ROICPCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

PCN's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of PCN has remained more or less at the same level.
In the last couple of years the Gross Margin of PCN has remained more or less at the same level.
Industry RankSector Rank
OM 81.26%
PM (TTM) 59.34%
GM 81.57%
OM growth 3Y-1.05%
OM growth 5Y-1.27%
PM growth 3Y-13.95%
PM growth 5Y-22.84%
GM growth 3Y-1.03%
GM growth 5Y-1.27%
PCN Yearly Profit, Operating, Gross MarginsPCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 150 200

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for PCN has been increased compared to 1 year ago.
PCN has more shares outstanding than it did 5 years ago.
PCN has a better debt/assets ratio than last year.
PCN Yearly Shares OutstandingPCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
PCN Yearly Total Debt VS Total AssetsPCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.41 indicates that PCN is not in any danger for bankruptcy at the moment.
PCN has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 3.41
ROIC/WACCN/A
WACCN/A
PCN Yearly LT Debt VS Equity VS FCFPCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

2.3 Liquidity

PCN has a Current Ratio of 0.16. This is a bad value and indicates that PCN is not financially healthy enough and could expect problems in meeting its short term obligations.
PCN has a Quick Ratio of 0.16. This is a bad value and indicates that PCN is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
PCN Yearly Current Assets VS Current LiabilitesPCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for PCN have decreased strongly by -71.68% in the last year.
The earnings per share for PCN have been decreasing by -21.77% on average. This is quite bad
PCN shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.15%.
The Revenue has been growing slightly by 6.29% on average over the past years.
EPS 1Y (TTM)-71.68%
EPS 3Y-15.3%
EPS 5Y-21.77%
EPS Q2Q%140.99%
Revenue 1Y (TTM)20.15%
Revenue growth 3Y6.09%
Revenue growth 5Y6.29%
Sales Q2Q%-3.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PCN Yearly Revenue VS EstimatesPCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.39 indicates a correct valuation of PCN.
When comparing the Price/Earnings ratio of PCN to the average of the S&P500 Index (28.79), we can say PCN is valued slightly cheaper.
Industry RankSector Rank
PE 15.39
Fwd PE N/A
PCN Price Earnings VS Forward Price EarningsPCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCN Per share dataPCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.81%, PCN is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.47, PCN pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.81%

5.2 History

The dividend of PCN has a limited annual growth rate of 0.99%.
PCN has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0.99%
Div Incr Years0
Div Non Decr Years0
PCN Yearly Dividends per sharePCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

PCN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-82.53%
EPS Next 2YN/A
EPS Next 3YN/A
PCN Yearly Income VS Free CF VS DividendPCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

More info and screens

PIMCO CORPORATE & INCOME STR

NYSE:PCN (4/25/2025, 8:04:00 PM)

After market: 12.6984 +0.08 (+0.62%)

12.62

+0.1 (+0.8%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-03 2025-03-03
Earnings (Next)09-22 2025-09-22
Inst Owners18.46%
Inst Owner Change-0.5%
Ins OwnersN/A
Ins Owner Change0%
Market Cap807.43M
Analysts0
Price TargetN/A
Short Float %0.27%
Short Ratio0.6
Dividend
Industry RankSector Rank
Dividend Yield 9.81%
Yearly Dividend1.34
Dividend Growth(5Y)0.99%
DP-82.53%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-11 2025-04-11 (0.1125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.39
Fwd PE N/A
P/S 11.79
P/FCF N/A
P/OCF N/A
P/B 1.3
P/tB 1.3
EV/EBITDA N/A
EPS(TTM)0.82
EY6.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.07
BVpS9.74
TBVpS9.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.35%
ROE 6.52%
ROCE 8.83%
ROIC 5.85%
ROICexc 5.86%
ROICexgc 6.02%
OM 81.26%
PM (TTM) 59.34%
GM 81.57%
FCFM N/A
ROA(3y)4.24%
ROA(5y)4.86%
ROE(3y)6.8%
ROE(5y)6.95%
ROIC(3y)5.35%
ROIC(5y)5.2%
ROICexc(3y)5.35%
ROICexc(5y)5.2%
ROICexgc(3y)5.49%
ROICexgc(5y)5.33%
ROCE(3y)9.05%
ROCE(5y)8.43%
ROICexcg growth 3Y10.31%
ROICexcg growth 5Y6.81%
ROICexc growth 3Y10%
ROICexc growth 5Y6.5%
OM growth 3Y-1.05%
OM growth 5Y-1.27%
PM growth 3Y-13.95%
PM growth 5Y-22.84%
GM growth 3Y-1.03%
GM growth 5Y-1.27%
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 3.41
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.68%
EPS 3Y-15.3%
EPS 5Y-21.77%
EPS Q2Q%140.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)20.15%
Revenue growth 3Y6.09%
Revenue growth 5Y6.29%
Sales Q2Q%-3.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.24%
EBIT growth 3Y4.98%
EBIT growth 5Y4.95%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y176.09%
FCF growth 3Y387.38%
FCF growth 5Y16.51%
OCF growth 1Y176.09%
OCF growth 3Y387.38%
OCF growth 5Y16.51%